What BMI Do You Need for Semaglutide or Tirzepatide? (Queens NY Guide)

The short answer

Most people qualify for a GLP-1 medication if their BMI is 30 or higher, or 27 or higher when paired with a weight-related health condition such as type 2 diabetes, high blood pressure (hypertension), or obstructive sleep apnea.

That said, I want to be honest with you up front: BMI is a screening tool, not a diagnosis. It's a useful starting point, but it doesn't see your muscle mass, your bloodwork, your family history, or how your weight is actually affecting your health. The final decision about whether Semaglutide or Tirzepatide is right for you is made by a physician — in our case, by me, Dr. Keisha Bryant, MD, board-certified in internal medicine — at your free 15-minute consult.

I'm writing this from my practice in St Albans, Queens, where I have this exact conversation almost every day. Let's walk through it the way I would in the room.

How to calculate your BMI

Body Mass Index is a simple ratio of your weight to your height. You don't need to do the math by hand — but here's the formula so you understand what the number means:

BMI = weight (kg) ÷ height (m)²

>

Or, in pounds and inches: BMI = (weight in lbs ÷ height in inches²) × 703

So for example, someone who is 5'5" (65 inches) and weighs 180 lbs has a BMI of roughly 30 — right at the common threshold.

Here's how the standard categories break down:

If you'd rather not do the arithmetic, our GLP-1 eligibility quiz walks you through it in under two minutes and tells you whether you're likely a candidate.

The two BMI thresholds that matter

This is the part patients most want clarified, so let me make it plain. There are two doorways into GLP-1 eligibility:

• BMI of 30 or higher. If your BMI is 30+, you generally meet the threshold on weight alone — no other condition required.
• *BMI of 27 or higher plus a weight-related comorbidity.* If your BMI is between 27 and 29.9, you can still qualify if you also have a condition driven or worsened by excess weight. The most common ones are:

- Type 2 diabetes (or prediabetes) - High blood pressure (hypertension) - Obstructive sleep apnea - High cholesterol, fatty liver, or PCOS are also frequently relevant

The logic is simple: at a BMI of 27, the medication is justified when your weight is already harming your health in a measurable way. At 30, the weight itself is enough.

Why BMI is only a screening tool — not the whole story

I'll be direct, because over-relying on a single number does patients a disservice. BMI has real limits:

• It doesn't distinguish muscle from fat. A muscular person can have a "high" BMI without excess body fat. This matters for athletes and very strong-framed patients.
• It doesn't account for where you carry weight. Visceral fat around the organs (often showing as belly fat) is more metabolically dangerous than fat elsewhere — and BMI can't see that. This is one reason I also look at waist circumference and labs.
• It can read differently across body types and ethnicities. For some patients, weight-related health risk appears at a slightly lower BMI than the standard cutoffs suggest.
• It says nothing about your bloodwork. Your A1c, fasting glucose, blood pressure, thyroid, and lipid panel tell me far more about whether a GLP-1 is appropriate than BMI alone.

This is exactly why eligibility is decided by a physician, not a calculator. BMI gets you in the door for a conversation; your full clinical picture decides what happens next.

What the GLP-1 medications actually are

Two FDA-approved options, named by their active ingredient:

• Semaglutide — the same active ingredient as Ozempic and Wegovy. In the STEP clinical-trial program, participants lost roughly 10–15% of body weight over about 12 months. Individual results vary.
• Tirzepatide — the same active ingredient as Mounjaro and Zepbound. In the SURMOUNT clinical-trial program, participants lost roughly 15–22% of body weight over 72 weeks. Individual results vary.

We dispense FDA-approved medication from a licensed U.S. pharmacy — never compounded online or drop-shipped. You can read the full comparison on our Semaglutide and Tirzepatide pages.

Figures are clinical-trial averages; they are not a guarantee of individual results.

How treatment is supervised

A GLP-1 isn't a vending-machine prescription, and it shouldn't be. Every patient here is supervised by Dr. Keisha Bryant, MD, and the program includes:

• A monthly MD check-in to review progress and adjust
• Dose titration — we start low and increase slowly over 4–8 weeks
• Lab monitoring before and during treatment
• Unlimited messaging and a nutrition plan

That structure is what makes the medication both safe and effective. A telehealth site that never sees your bloodwork can't do this.

Common side effects — the honest version

Most people tolerate these medications well, but I want you to know what's normal:

• Mild nausea, indigestion, and constipation are the most common effects.
• They usually show up during dose increases and tend to resolve within a week.
• To minimize them, I titrate the dose slowly over 4–8 weeks rather than rushing.

Knowing this in advance is half the battle — most patients who quit early do so because no one prepared them.

Talk to us first if…

A GLP-1 is not right for everyone. Please tell me before starting if any of these apply to you:

• You are pregnant, breastfeeding, or planning pregnancy
• You have a personal or family history of medullary thyroid cancer, or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
• You have a history of pancreatitis
• You take medications that may interact with a GLP-1

These aren't fine print — they're the reason a real physician screens you first.

What it costs

Our pricing is all-inclusive with no surprise add-ons:

• $199/mo (Semaglutide) and $250/mo (Tirzepatide), all-inclusive — covers medication, monthly MD check-in, dose titration, labs, unlimited messaging, and a nutrition plan.

How to find out if you qualify

You have two easy next steps:

1. 1Take our quick GLP-1 eligibility quiz — it estimates your BMI and flags relevant conditions in about two minutes.
2. 2Book a free 15-minute consult and we'll review your BMI, your history, and your labs together. I make the final eligibility decision in that conversation, with your full picture in front of me.

We're at 205-15 Hollis Avenue, St Albans, NY 11412, open Mon–Sat 9–5, and you can reach us at +1 (718) 217-3744. If your BMI is even close to these thresholds, it's worth a conversation — let's find out together.

Note: This article is educational and not medical advice. BMI thresholds are general screening guidelines; medications and weight-loss plans are individualized and prescribed only within a physician-patient relationship. Results vary.